AbbVie (ABBV) FCF Margin (2012 - 2026)
AbbVie (ABBV) recorded FCF Margin of 18.33% in Q2 2026, down 13.34 percentage points from 31.67% a year earlier and down 5.43 percentage points from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) FCF Margin (2012 - 2026) Analysis & Trends
On a TTM basis, AbbVie's FCF Margin came in at 28.28% as of Jun 30, 2026, down 2.99 percentage points year-over-year; for FY2025, it came in at 29.13%, down 2.52 percentage points from FY2024.
- Annual FCF Margin has declined for three straight years, with a five-year change of -7.53 percentage points (FY2020 to FY2025).
- Across earlier years, FCF Margin came in at 31.65% in FY2024 (-8.96 pp), 40.62% in FY2023 (-1.15 pp), 41.77% in FY2022 (+2.64 pp) and 39.13% in FY2021 (+2.47 pp).
- The Q2 2026 figure is the lowest quarterly FCF Margin since Q1 2025.
- On a year-over-year basis, FCF Margin rose in four of the last eight quarters, with an average year-over-year change of -2.04 percentage points.
- Peak year-over-year performance for FCF Margin in the last five years was a gain of 17.63 percentage points in Q2 2025, against a drop of 30.25 percentage points in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 23.76% (Q1 2026), 29.42% (Q4 2025) and 42.11% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 28.82% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 43.05% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 34.72% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 2.01% |
| 10 | Vertex Pharmaceuticals | 128.38 Bn | 100.39 Bn | 2.84 Bn | 30.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.33% |
| Mar 31, 2026 | 23.76% |
| Dec 31, 2025 | 29.42% |
| Sep 30, 2025 | 42.11% |
| Jun 30, 2025 | 31.67% |
| Mar 31, 2025 | 10.49% |
| Dec 31, 2024 | 44.74% |
| Sep 30, 2024 | 35.95% |
| Jun 30, 2024 | 14.04% |
| Mar 31, 2024 | 31.25% |
| Dec 31, 2023 | 31.80% |
| Sep 30, 2023 | 52.81% |
| Jun 30, 2023 | 44.29% |
| Mar 31, 2023 | 32.87% |
| Dec 31, 2022 | 47.72% |
| Sep 30, 2022 | 50.13% |
| Jun 30, 2022 | 33.34% |
| Mar 31, 2022 | 35.06% |
| Dec 31, 2021 | 32.84% |
| Sep 30, 2021 | 53.81% |
API Access
AbbVie FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();